Download Product Catalogue

Product Detail

KALSTIN-4.5

Kalstin-4.5

Colistimethate 4.5 MIU Injection

Carbapenem resistance to bacterial infections Hospital-acquired pneumonia (HAP/VAP).

Carbapenem resistance to bacterial infections Hospital-acquired pneumonia (HAP/VAP) Treatment Active against resistant bacteria bloodstream infections and meningitis Applied in complex intra-abdominals infections.

MRP: ₹4850/-
Send Enquiry

100%

Certified Products

Secure

pAYMENTS

24/7

Customer Support

100%

Certified Products

Secure

PAYMENTS

24/7

Customer Support

About The Product

Uses

Carbapenem resistance to bacterial infections Hospital-acquired pneumonia (HAP/VAP) Treatment Active against resistant bacteria bloodstream infections and meningitis Applied in complex intra-abdominals infections.

Side Effects

  • Kidney damage (kidney damage, nephrotoxicity) Neurotoxicity (dizziness, confusion, muscle weakness, tingling or seizures) Pain, redness or swelling on the place of injections Hypomagnesaemia or hypokalaemia Allergies (rash, itchiness, air trouble)

Uses

Carbapenem resistance to bacterial infections Hospital-acquired pneumonia (HAP/VAP) Treatment Active against resistant bacteria bloodstream infections and meningitis Applied in complex intra-abdominals infections.

Side Effects

  • Kidney damage (kidney damage, nephrotoxicity) Neurotoxicity (dizziness, confusion, muscle weakness, tingling or seizures) Pain, redness or swelling on the place of injections Hypomagnesaemia or hypokalaemia Allergies (rash, itchiness, air trouble)

Indications

  • Severe Gram negative bacterial infections There are several treatment indications when it comes to severe Gram negative bacterial infections: Active against multi-drug resistant (MDR) organisms particularly Pseudomonas aeruginosa and Acinetobacter baumannii Applied in respiratory tract infections, urinary tract infections, intra-abdominal infections, bacteremia and sepsis Lately, it is usually used to treat acutely ill patients in ICU when other antibiotics prove futile

FAQ

Q1: How is Colistimethate 4.5 MIU used?
It is utilised to treat the life threatening multidrug resistant Gram-negative infections particularly in the ICU patients.

Q2: Is it suitable to children?
Yes, however, it should be dosed strictly, by a physician, based on body mass and the degree of the infection.

Q3: Is it kidney safe?
Colistimethate can lead to the kidney damage; during the treatment, the patients should have regular kidney functions monitoring.

Q4: How is it given?
It is normally administered through slow IV under medical prescription.

Q5: Is it combinable with other antibiotics?
Yes, and most commonly with combination therapy in carbapenems or tigecycline to achieve improved results.

Indications

  • Severe Gram negative bacterial infections There are several treatment indications when it comes to severe Gram negative bacterial infections: Active against multi-drug resistant (MDR) organisms particularly Pseudomonas aeruginosa and Acinetobacter baumannii Applied in respiratory tract infections, urinary tract infections, intra-abdominal infections, bacteremia and sepsis Lately, it is usually used to treat acutely ill patients in ICU when other antibiotics prove futile

FAQ

Q1: How is Colistimethate 4.5 MIU used?
It is utilised to treat the life threatening multidrug resistant Gram-negative infections particularly in the ICU patients.

Q2: Is it suitable to children?
Yes, however, it should be dosed strictly, by a physician, based on body mass and the degree of the infection.

Q3: Is it kidney safe?
Colistimethate can lead to the kidney damage; during the treatment, the patients should have regular kidney functions monitoring.

Q4: How is it given?
It is normally administered through slow IV under medical prescription.

Q5: Is it combinable with other antibiotics?
Yes, and most commonly with combination therapy in carbapenems or tigecycline to achieve improved results.

Request a Callback